Rethinking spinal anesthetic with bupivacaine for cesarean delivery in parturient with Brugada syndrome
Janice Yu, Cameron Nishi, Elaheh Adly, Daniel Cordovani
References
1. Vutthikraivit W, Rattanawong P, Putthapiban P, et al. Worldwide prevalence of Brugada syndrome: a systematic review and meta-analysis [published correction appears in Acta Cardiol Sin. 2019 Mar;35(2):192] Acta Cardiol Sin. 2018;34:267−77.
2. Postema PG, Wolpert C, Amin AS, et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm. 2009;6:1335−41.
3. Jarraya A, Chayeb I, Kammoun M, Derbel M, Fatma K, Kolsi K. Spinal anesthesia for a rare case of Brugada syndrome undergoing cesarean section delivery. Tunis Chir. 2018;2018 http://www.tunisiechirurgicale.com/Article_240_spinal_anesthesia_for_a_rare_case_of_brugada_syndrome_undergoing_cesarean_section_delivery.html.
4. Kloesel B, Ackerman MJ, Sprung J, Narr BJ, Weingarten TN. Anesthetic management of patients with Brugada syndrome: A case series and literature review. Can J Anesth. 2011;58:824−36.
5. Kam PCA, Cardone D. Propofol infusion syndrome. Anesthesia. 2007;62:690−701.
Submitted date:
07/19/2022
Accepted date:
08/31/2022